PBOC Measures: The People's Bank of China has lowered interest rates on various monetary policy tools, positively impacting the Hong Kong stock market, with the HSI, HSCEI, and HSTECH all opening higher.
Kuaishou and Other Tech Stocks: Kuaishou's stock rose 1.6% after issuing senior notes, while Alibaba and Tencent also saw gains, although some tech stocks like JD and Baidu experienced slight declines.
CKH Holdings Plans: CKH Holdings is planning to list A.S. Watson in Hong Kong and London by 2Q26, aiming for a valuation of $30 billion, which boosted its share price by 2.2%.
Wuxi Bio's Shareholder Action: Wuxi Biologics' stock fell 3.4% after its major shareholder sold shares at a discount, resulting in a significant cash-out of over $5.7 billion.
Wall Street analysts forecast 00001 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00001 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast 00001 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00001 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 61.350
Low
Averages
High
Current: 61.350
Low
Averages
High
Bank of America Securities
BofAS
Buy
maintain
$62 -> $67
2026-01-21
New
Reason
Bank of America Securities
BofAS
Price Target
$62 -> $67
AI Analysis
2026-01-21
New
maintain
Buy
Reason
The analyst rating from the UBS research report is a "Buy" recommendation for CKH Holdings, driven by optimism about the company's potential to unlock value through asset sales, particularly in light of discussions to sell its Irish telecom operator, Three Ireland. The report highlights that the sale could enhance market expectations for CKH's engagement in mergers and acquisitions (M&A) in other operational markets. The target price set by the broker is HKD67, reflecting confidence in the company's strategic moves.
CLSA
CLSA
Outperform
maintain
$61
2026-01-21
New
Reason
CLSA
CLSA
Price Target
$61
2026-01-21
New
maintain
Outperform
Reason
The analyst rating for CKH HOLDINGS is "Outperform" based on the potential sale of its Irish telecom business to Liberty Global for EUR1.5 billion. This transaction is viewed positively as it allows CKH HOLDINGS to exit a stressed telecom business at an attractive valuation, with an EV/EBITDA multiple of 11.4x for 2026/2027, significantly higher than the industry average of 5.9x. Additionally, the sale is expected to boost the company's overall net asset value by approximately 3% in 2026, although the impact on earnings is anticipated to be minimal. The broker has set a target price of $61 for the stock, reinforcing its position as one of the top picks for 2026.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 00001
Unlock Now
Morgan Stanley
Morgan Stanley
initiated
$61
2026-01-19
New
Reason
Morgan Stanley
Morgan Stanley
Price Target
$61
2026-01-19
New
initiated
Reason
The analyst rating from Morgan Stanley for CKH HOLDINGS (00001.HK) is based on several key factors:
1. Positive Growth Expectations: Morgan Stanley anticipates positive growth in both Earnings Per Share (EPS) and Dividends Per Share (DPS) for CKH, particularly with the upcoming announcement of its 2025 results in March.
2. Corporate Actions: The broker expects that certain corporate actions will add value to the stock price and help narrow the discount to Net Asset Value (NAV).
3. High Probability of Success: Morgan Stanley estimates the probability of these positive outcomes occurring to be over 80%, which they describe as "highly likely."
These factors collectively led to the assignment of an Overweight rating and a target price of HKD61 for the stock.
UBS
UBS
upgrade
$67
2026-01-19
New
Reason
UBS
UBS
Price Target
$67
2026-01-19
New
upgrade
Reason
The analyst rating from UBS is influenced by several factors. They noted that the stock performance of Hong Kong conglomerates in 2025 was driven by asset sales and capital recovery activities. UBS observed a shift in investor focus towards valuing companies based on their price-to-book (P/B) ratio rather than dividend yield. Additionally, they anticipate that upcoming Federal Reserve rate cuts will further encourage asset sales. As a result, UBS has given CKH HOLDINGS a Buy rating, raising its target price from HKD 58.8 to HKD 67, indicating a positive outlook based on these market dynamics. In contrast, SWIRE PACIFIC A has been rated as Neutral, with a lowered target price, reflecting a more cautious stance.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
